Global knowledge map of sentinel lymph node fluorescence mapping in endometrial carcinoma: a visual analysis

Endometrial carcinoma (EC) is a prevalent gynecological malignancy in which sentinel lymph node (SLN) fluorescence mapping technique is utilized for staging the diseases and adjuvant treatment guidance. Herein, we aim to assess the research focus on global SLN mapping and determine potential new directions through bibliometric analysis. Articles related to SLN fluorescence mapping of EC from 2000 to October 2022 were searched from the Web of Science database, and research progress in this field was analyzed using bibliometric software HistCite Pro 2.1, VOSviewer 1.6.18 and CiteSpace 5.8.3Rc. A total of 197 related articles published from 2000 to 2022 were identified, and we observed that the number of publications had increased rapidly since 2015. The leading countries in this research area are the United States and Italy. The most influential institutions in this field with close collaboration are located in the United States, Italy and Switzerland. The journal with the highest number of high-quality publications is Gynecologic Oncology. In regards to publication authors, notable contributions have been made by Buda A, Papadia A and Rossi EC in this field. The most recent co-cited cluster label is “#notes”, and we found that the current research is focused on optimizing fluorescence mapping technology and improving detection accuracy. With the growing emphasis on lymph node (LN) metastasis, there has been increasing attention on SLN fluorescence mapping. Currently, research in this area primarily focuses on addressing controversial issues, such as investigating factors contributing to mapping failure and investigating ways to enhance the surgical algorithm for improved outcomes.

Bibliometric; CiteSpace; Endometrial carcinoma; HistCite; SLN mapping; Vosviewer

[1] Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA: A Cancer Journal for Clinicians. 2022; 72: 409–436.

[2] Volpi L, Sozzi G, Capozzi VA, Ricco’ M, Merisio C, Di Serio M, et al. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience. International Journal of Gynecologic Cancer. 2019; 29: 312–319.

[3] Tortorella L, Casarin J, Multinu F, Cappuccio S, McGree ME, Weaver AL, et al. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping. Gynecologic Oncology. 2019; 155: 34–38.

[4] Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, et al. Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2023; 21: 181–209.

[5] Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. International Journal of Gynecologic Cancer. 2021; 31: 12–39.

[6] Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Radiotherapy and Oncology. 2021; 154: 327–353.

[7] Xue Y, Shan W, Wang Q, Wang C, Luo X, Chen X. Efficacy of sentinel lymph node mapping in endometrial cancer with low- or high-intermediate risk. Journal of Surgical Oncology. 2022; 125: 256–263.

[8] Nagar H, Wietek N, Goodall RJ, Hughes W, Schmidt-Hansen M, Morrison J. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer. The Cochrane Database of Systematic Reviews. 2021; 6: CD013021.

[9] Gedgaudaite M, Sukovas A, Paskauskas S, Bartusevicius A, Atstupenaite V, Svedas E, et al. The feasibility of sentinel lymph-node, mapped with indocyanine green, biopsy in endometrial cancer patients: a prospective study. Medicina. 2022; 58: 712.

[10] Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, et al. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—a meta-analysis. Annals of Surgical Oncology. 2016; 23: 3749–3756.

[11] Feng LF, Yan PJ, Chu XJ, Zhang N, Li JY, Li JW, et al. A scientometric study of the top 100 most-cited publications based on web-of-science regarding robotic versus laparoscopic surgery. Asian Journal of Surgery. 2021; 44: 440–451.

[12] Agarwal A, Baskaran S, Panner Selvam MK, Barbăroșie C, Master K. Unraveling the footsteps of proteomics in male reproductive research: a scientometric approach. Antioxidants & Redox Signaling. 2020; 32: 536–549.

[13] Zhong D, Luo S, Zheng L, Zhang Y, Jin R. Epilepsy occurrence and circadian rhythm: a bibliometrics study and visualization analysis via CiteSpace. Frontiers in Neurology. 2020; 11: 984.

[14] Wang H, Shi J, Shi S, Bo R, Zhang X, Hu Y. Bibliometric analysis on the progress of chronic heart failure. Current Problems in Cardiology. 2022; 47: 101213.

[15] Zhou H, Tan W, Qiu Z, Song Y, Gao S. A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015. PeerJ. 2018; 6: e4354.

[16] Guo Y, Hao Z, Zhao S, Gong J, Yang F. Artificial intelligence in health care: bibliometric analysis. Journal of Medical Internet Research. 2020; 22: e18228.

[17] van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017; 111: 1053–1070.

[18] Arruda H, Silva ER, Lessa M, Proença D Jr, Bartholo R. VOSviewer and Bibliometrix. Journal of the Medical Library Association. 2022; 110: 392–395.

[19] Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annual Symposium Proceedings. 2005; 2005: 724–728.

[20] Zhong D, Li Y, Huang Y, Hong X, Li J, Jin R. Molecular mechanisms of exercise on cancer: a bibliometrics study and visualization analysis via CiteSpace. Frontiers in Molecular Biosciences. 2022; 8: 797902.

[21] Cabrera S, Barahona-Orpinell M, Almansa-González C, Padilla-Iserte P, Bebia V, Martí L, et al. Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer: results of the COMBITEC study. Gynecologic Oncology. 2021; 162: 32–37.

[22] Kessous R, How J, Abitbol J, Puzhakkal S, Kogan L, Yasmeen A, et al. Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment. International Journal of Gynecologic Cancer. 2019; 29: 1121–1125.

[23] Jewell EL, Huang JJ, Abu-Rustum NR, Gardner GJ, Brown CL, Sonoda Y, et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecologic Oncology. 2014; 133: 274–277.

[24] Small H. Co-citation in the scientific literature: a new measure of the relationship between documents. Journal of the American Society for Information Science. 1973; 24: 265–269.

[25] Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. The Lancet Oncology. 2017; 18: 384–392.

[26] Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. The Lancet Oncology. 2018; 19: 1394–1403.

[27] Cusimano MC, Vicus D, Pulman K, Maganti M, Bernardini MQ, Bouchard-Fortier G, et al. Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surgery. 2021; 156: 157–164.

[28] Baiocchi G, Andrade CEMC, Ribeiro R, Moretti-Marques R, Tsunoda AT, Alvarenga-Bezerra V, et al. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial). International Journal of Gynecologic Cancer. 2022; 32: 676–679.

[29] Persson J, Salehi S, Bollino M, Lönnerfors C, Falconer H, Geppert B. Pelvic sentinel lymph node detection in high-risk endometrial cancer (SHREC-trial)—the final step towards a paradigm shift in surgical staging. European Journal of Cancer. 2019; 116: 77–85.

[30] Bollino M, Geppert B, Lönnerfors C, Falconer H, Salehi S, Persson J. Pelvic sentinel lymph node biopsy in endometrial cancer—a simplified algorithm based on histology and lymphatic anatomy. International Journal of Gynecologic Cancer. 2020; 30: 339–345.

[31] Mathey MP, Romito F, Huber DE. Retroperitoneal sentinel lymph node biopsy by vaginally assisted natural orifices endoscopic transluminal endoscopic surgery in early stage endometrial cancer: description of technique and surgeon’s perspectives after the first experience. Case Reports in Oncology. 2022; 15: 291–299.

[32] Oh SH, Park SJ, Lee EJ, Yim GW, Kim HS. Pelvic lymphadenectomy by vaginal natural orifice transluminal endoscopic surgery (vNOTES) for early-stage endometrial cancer. Gynecologic Oncology. 2019; 153: 211–212.

[33] Abdullah NA, Huang K, Casanova J, Artazcoz S, Jarruwale P, Benavides DR, et al. Sentinel lymph node in endometrial cancer: a systematic review on laparoscopic detection. Gynecology and Minimally Invasive Therapy. 2013; 2: 75–78.

[34] Mat E, Kale A, Gundogdu EC, Basol G, Yildiz G, Usta T. Transvaginal natural orifice endoscopic surgery for extremely obese patients with early-stage endometrial cancer. The Journal of Obstetrics and Gynaecology Research. 2021; 47: 262–269.

[35] Kapurubandara S, Lowenstein L, Salvay H, Herijgers A, King J, Baekelandt J. Consensus on safe implementation of vaginal natural orifice transluminal endoscopic surgery (vNOTES). European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 263: 216–222.

[36] Li Y, Hou Q, Gong Z, Huang L, He L, Lin Y. Sentinel lymph node mapping and staging surgery via gasless transvaginal natural orifice transluminal endoscopic surgery: a case report of an endometrial cancer patient and comorbid rheumatic heart disease. American Journal of Case Reports. 2022; 23: e936694.

[37] Wang Y, Deng L, Tang S, Dou Y, Yao Y, Li Y, et al. VNOTES hysterectomy with sentinel lymph node mapping for endometrial cancer: description of technique and perioperative outcomes. Journal of Minimally Invasive Gynecology. 2021; 28: 1254–1261.

[38] Raffone A, Travaglino A, Mascolo M, Carotenuto C, Guida M, Mollo A, et al. Histopathological characterization of ProMisE molecular groups of endometrial cancer. Gynecologic Oncology. 2020; 157: 252–259.